SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: DRRISK who wrote (1092)2/23/1998 6:50:00 PM
From: Premier  Respond to of 2068
 
Good luck to you.

IMHO, price decline today was due to last minute uncertainty in KKR package deal. A signed deal will lift the moral of this stock. IMHO, market has discounted $2.50 per share loss for the quarter. Excess loss will cause temporary minor dent in the price after thursday 4pm. Any price weakness should be viewed as buying opportunity.

I do not know about short term performance of this stock. The market has show me! attitude because public has bad memories about this stock.

Premier



To: DRRISK who wrote (1092)2/23/1998 7:26:00 PM
From: Don Wong  Read Replies (1) | Respond to of 2068
 
Looks like you made your move based on reports from the Wall Street Journal. No doubt WSJ is a highly respected source, still neither OXHP nor KKR has made any official announcement. One area I have trouble to understand is will KKR make the offer with knowledge of what the Q4 numbers are going to be, or the offer is subject to change with release of the Q4 ?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News